Picture of Vivesto AB logo

VIVE Vivesto AB News Story

0.000.00%
se flag iconLast trade - 00:00
HealthcareHighly SpeculativeMicro CapSucker Stock

Brief: Oasmia: European Patent Office To Grant Xmena Patent

March 24 (Reuters) - Oasmia Pharmaceutical AB  OASM.ST :
    * EUROPEAN PATENT OFFICE INFORMS OASMIA OF ITS INTENTION TO GRANT XMENA PATENT
    * XMENA PATENT PROTECTS AN IMPROVED METHOD FOR MANUFACTURING PROCESS FOR OASMIA'S
NANOTECHNOLOGY
PLATFORM XR-17

Source text for Eikon:  ID:nMFN9jQ7Tp 
Further company coverage:  OASM.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 778 51 10;))

Recent news on Vivesto AB

See all news